D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to…


Learn more

MRM Insights: Asymmetric cell division and cancer cell stemness

Every month, in MRM Insights, a member of the MRM Network is writing about stem…


Learn more

Copyright © 2019 McGill Regenerative Medicine Network. All rights reserved. Website by KORSR Studio, Valérie Provost & ER5.